Ann: Annual Report to shareholders, page-18

Recently the SP climbed to almost the equivalent of the 3.0 cents preconsolidation.
The basis for this was an announcement regarding Covid antibody tests.
This was Mr Market at work not the CEO or board.
If Mr Market is that interested to drive CDY up to that level without any substantial cash inflow prior to the Capital Raise what is going to happen when they become cashflow positive with evolis or we discover that they are involved in a similar or supporting way to something like this.

https://www.baltimoresun.com/coronavirus/bs-md-hopkins-coronavirus-plasma-antibodies-20200917-alphvw4j5zduvguukqg56g2s5e-story.html

If that became a way of treating coronavirus then antibody tests will become the norm.

Would also like to point out that the TGA listings for antibody tests, PCR swabs,now exceed 50 which is a lot more than previously.
If the association with these tests is as unviable as it is made out at times why are more and more climbing into it?
There is a lot to be done yet.